Document Detail

Further development of artificial pancreas: blocked by patents?
MedLine Citation:
PMID:  19885286     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Patent activity in the field of medical device technology and especially in the area of artificial pancreas development has surged in recent years. According to the search presented in this article, the number of granted U.S. patents in the area of closed-loop glucose control (CLGC) increased from 24 filed in 1991 to 247 filed in 2001. A company active in the area of diabetes technology development will likely need to understand a patent landscape consisting of hundreds of patents. Currently, both in the United States and in Europe, patentability requirements seem to be raised in order to ensure patent quality. However, the current patent landscape reflects the work of the patent offices in the past, as already granted patents are not affected by changes made to the patent grant procedure today.Regarding the increasing amount of patents and considering the complexity of CLGC systems, the attempt to develop a CLGC system will become more and more venturesome regarding the risk of infringement of already existing patents. The consequence of this situation can be that less innovation takes place.This article highlights some important general aspects of the patent system, briefly characterizes the current CLGC patent landscape, and illustrates by means of two exemplary patents what one angle of said patent landscape looks like. It is our opinion that, in order to support the rapid development of an artificial pancreas for patients with diabetes, adequate action to lower this hurdle should be undertaken by a consortium of all parties involved (industries, patient organizations, health-care professionals, and institutional payers).
Nils Erdin; Franck Robin; Lutz Heinemann; Derek Brandt; Roman Hovorka
Related Documents :
20199136 - Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to...
20394886 - Addressing barriers to initiation of insulin in patients with type 2 diabetes.
20880046 - Does higher quality of diabetes management in family practice reduce unplanned hospital...
18352966 - Health literacy, complication awareness, and diabetic control in patients with type 2 d...
9244206 - Cardiovascular risk factors in mexican-american and non-hispanic white children: the co...
9881956 - Angiogenesis in breast cancer: a comparative study of the observer variability of metho...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of diabetes science and technology     Volume:  2     ISSN:  1932-2968     ISO Abbreviation:  J Diabetes Sci Technol     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2009-11-03     Completed Date:  2009-12-15     Revised Date:  2013-05-23    
Medline Journal Info:
Nlm Unique ID:  101306166     Medline TA:  J Diabetes Sci Technol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  971-6     Citation Subset:  -    
Sensile Medical AG, Hägendorf, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of implementation of a fully automated algorithm (enhanced model predictive control) in a...
Next Document:  Percutaneous window chamber method for chronic intravital microscopy of sensor-tissue interactions.